Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

2.66
Delayed Data
As of Jan 23
 -0.10 / -3.62%
Today’s Change
1.65
Today|||52-Week Range
6.19
+6.40%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close2.76
Today’s open2.78
Day’s range2.57 - 2.85
Volume54,011
Average volume (3 months)95,242
Market cap$36.6M
Dividend yield--
Data as of 01/23/2017

Growth & Valuation

Earnings growth (last year)-49.55%
Earnings growth (this year)+20.48%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+485.21%
P/E ratioNM
Price/Sales6.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TPIVTapImmune Inc-0.09-2.05%
DMPIDelMar Pharmaceutica...+0.23+6.59%
RPRXRepros Therapeutics ...-0.08-5.67%
THLDThreshold Pharmaceut...+0.01+2.86%
Data as of 01/23/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$9.7M
Annual profit (last year)-$15.9M
Net profit margin-163.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Operations Director
Joe Bitterman
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs